| Literature DB >> 32711443 |
Daniel Augusto Nunes De Lima1, Brenda Barroso Pelegrini1, Felipe Alexandre Alves Uechi2, Raíssa Coracini Varago1, Bruno Bueno Pimenta1, Alice Maria De Souza Kaneshima1, Edilson Nobuyoshi Kaneshima2, Paola Da Costa Souza2, Raíssa Bocchi Pedroso1, Thaís Gomes Verzignassi Silveira3, Tânia Cristina Alexandrino Becker4.
Abstract
INTRODUCTION: Aberrant Crypt (AC) and Aberrant Crypt Focus (ACF) are considered pre-neoplasic lesions, ranging from hyperplasia to different degrees of dysplasia in the colon. This work aimed to evaluate and quantify the chemopreventive activity of Zingiber officinale essential oil in the colorectal region of Wistar rats.Entities:
Keywords: Aberrant crypt focus; Colorectal Neoplasms; Essential oil, Chemopreventive effect; Ginger - Zingiber officinale
Mesh:
Substances:
Year: 2020 PMID: 32711443 PMCID: PMC7573421 DOI: 10.31557/APJCP.2020.21.7.2141
Source DB: PubMed Journal: Asian Pac J Cancer Prev ISSN: 1513-7368
Chemical Composition of Ginger Essential Oil (Zingiber officinale) Analyzed by Gas chromatography
| Components | trA | n | m | Dn | trn | trm | IKA | % |
|---|---|---|---|---|---|---|---|---|
| α-Pinene | 6.45 | 9 | 10 | 1 | 5.54 | 8.64 | 929.35 | 3.39 |
| Camphene | 6.96 | 9 | 10 | 1 | 5.54 | 8.64 | 945.81 | 9.55 |
| D-Limonene | 9.63 | 9 | 10 | 1 | 5.54 | 8.64 | 1031.94 | 1.99 |
| β-Phellandrene | 9.70 | 10 | 11 | 1 | 8.64 | 12.58 | 1026.90 | 6.83 |
| Eucalyptol | 9.75 | 10 | 11 | 1 | 8.64 | 12.58 | 1028.17 | 6.68 |
| Borneol | 15.52 | 11 | 12 | 1 | 12.58 | 16.91 | 1167.90 | 1.08 |
| p-mentol-1-en-8-ol | 16.52 | 11 | 12 | 1 | 12.58 | 16.91 | 1190.99 | 1.27 |
| δ-Citronellol | 17.90 | 12 | 13 | 1 | 16.91 | 21.31 | 1222.50 | 0,28 |
| δ-Citral | 18.40 | 12 | 13 | 1 | 16.91 | 21.31 | 1233.86 | 10.25 |
| Trans-Geraniol | 18.93 | 12 | 13 | 1 | 16.91 | 21.31 | 1245.91 | 4.47 |
| Citral | 19.70 | 12 | 13 | 1 | 16.91 | 21.31 | 1263.41 | 17.25 |
| NerolAcetate | 24.47 | 13 | 14 | 1 | 21.31 | 25.61 | 1373.49 | 6.37 |
| Benzene | 28.71 | 14 | 15 | 1 | 25.61 | 29.72 | 1475.43 | 6.18 |
| (-)Zingiberene | 29.29 | 14 | 15 | 1 | 25.61 | 29.72 | 1489.54 | 7.57 |
| α-Farnesene | 29.7 | 14 | 15 | 1 | 25.61 | 29.72 | 1499.51 | 3.63 |
| Cyclohexene | 29.81 | 15 | 16 | 1 | 29.72 | 33.64 | 1502.30 | 2.29 |
| β-Sesquiphellandrene | 30.44 | 15 | 16 | 1 | 29.72 | 33.64 | 1518.37 | 4.57 |
n, number of alkane carbons eluting before "i"; m, number of alkane carbons eluting after "i"; Dn, "m"-"n"; tri, retention time of i (sample); trn, retention time of standard "n" (standard before); trm, retention time of pattern "m" (pattern after); IKA, 100*n + 100*Dn* (trA-trn/trm-trn); %, Percent of the compound.
Figure 1Animals Weight Assessment. The graph expresses the body weight in grams of the animals that compose the groups, monitored weekly and, the results presented, represents the average animals’ weight per group per week
Averages of Aberrant Crypts (AC) and Aberrant Crypt Foci (ACF), in the Proximal and Distal Regions of the Colon, in Experimental Groups of Induction with DMH (1,2 dimethylhydrazine) and Essential Oil Treatment Zingiber Officinale and 5-FU
| Proximal Colon | Distal Colon | |||||||
|---|---|---|---|---|---|---|---|---|
| CA | FCA | CA | FCA | |||||
| 1 crypt | 2-3 crypts | 4-9 crypts | ≥10 crypts | 1 crypt | 2-3 crypts | 4-9 crypts | ≥10 crypts | |
| GI | 0.25 ±0.5 | 0.00±0.0 | 0.00±0.0 | 0.00±0.0 | 0.00±0.0 | 0.00±0.0 | 0.75±1.5 | 0.00±0.0 |
| GII | 42.67±16.20 | 36.83±16.95 | 4.83±2.63 | 0.17±0.40 | 37.50±18.29 | 47.00±15.63 | 33.33±15.16 | 0.50±0.83 |
| GIII | 40.17±22.28b | 34.17±12.44b | 1.33±1.75a | 0.00±0.0 | 18.50±11.94a,b | 28.83±13.31a | 16.67±10.55a | 0.50±0.83 |
| GIV | 8.17±5.67 | 8.17±5.03 | 2.33±2.06 | 0.00±0.0 | 7.83±3.06 | 16.00±7.72 | 16.67±8.47 | 0.50±0.83 |
| GV | 0.00±0.0 | 0.00±0.0 | 0.00±0.0 | 0.00±0.0 | 0.00±0.0 | 0.00±0.0 | 0.00±0.0 | 0.00±0.0 |
AC, aberrant crypts; ACF, Aberrant Crypt Foci; GI, control group; GII, experimental group with DMH induction; GIII, experimental group with DMH induction + essential oil; GIV, experimental group with DMH + 5-FU induction; GV, experimental group with essential oil. Results expressed as average of the quantities observed in the animals of the same group ± standard deviation. a, Significant when compared to GII; b, Significant when compared to GIV. Significance when p<0.05.
Figure 2.Representative Images of the Study's Histological in Experimental Groups (GII, GIII and GIV). A, Colonic mucosa stained with methylene blue, representing a topographic view of an ACF with seven AC. The AC presents an irregular luminal opening and a thicker epithelial lining compared to normal adjacent crypts (light microscopy - 4x objective). B/C: Colonic mucosa stained with H E representing a topographic view; B, hyperplastic crypts, with abundant glandular formations. The luminal opening of ACF was slightly elevated from the normal mucosa, presenting several elongated crypt layers; C, dysplastic AC (black arrow) presented cells with marked cytoplasmic basophilia; high nucleus-cytoplasm ratio and loss of cell polarity in several degrees, nuclear stratification; and reduction in mucin production
Figure 3.Colon Photomicrographs Marked with PCNA and Developed with DAB. Crypt cells in the basal region of the crypt (red arrow) and crypt apex in experimental groups (GII, GIII and GIV) (black arrow) with marked expression of PCNA, presence of nuclear stratification and reduced mucin production (*).